KBIO LABS Inc. Q3 revenue KRW 11.1 billion, operating profit down 99.3% from a year earlier
KAI summary · Not investment advice
K-Bio Labs sold KRW 11.1 billion worth in Q3 and earned KRW 398,340 from its main business, down 99.3% from a year earlier and 99.9% from the prior quarter.
Operating profit · 3 months
KRW 398,340
Key facts
- Revenue (3 months)
- KRW 11.1 billion
- Net income (3 months)
- KRW -10.9 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 9.4 billion
- Revenue (year to date)
- KRW 32.8 billion
- Operating profit (prior-year 3 months)
- KRW 60.7 million
- Operating profit (year to date)
- KRW 324.4 million
- Net income (prior-year 3 months)
- KRW -136.6 million
- Net income (year to date)
- KRW -50.9 billion
Commentary
AI commentary · Not investment advice
What happened
Kbiolabs reported its third-quarter results on a standalone basis. Sales for the 3 months were KRW 11.06 billion. That is up 17.9% from the same period a year earlier and down 9.6% from the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 0.4 million. That is down 99.3% from the same period a year earlier, when it was KRW 60.7 million. It is down 99.9% from the previous quarter.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 10.92 billion. A year earlier, the same period showed a loss of KRW 136.6 million.
For the year so far, from January to September, sales were KRW 32.81 billion. Operating profit was KRW 324.4 million. Net income was a loss of KRW 50.86 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist